Li, Chenggong
Zhou, Fen
Wang, Jing
Chang, Qi
Du, Mengyi
Luo, Wenjing
Zhang, Yinqiang
Xu, Jia
Tang, Lu
Jiang, Huiwen
Liu, Lin
Kou, Haiming
Lu, Cong
Liao, Danying
Wu, Jianghua
Wei, Qiuzhe
Ke, Sha
Deng, Jun
Liu, Cheng
Mei, Heng
Hu, Yu
Funding for this research was provided by:
National Key R&D Program of China (2019YFC1316203, 2019YFC1316204)
National Natural Science Foundation of China (81873434)
Article History
Received: 13 November 2022
Accepted: 15 January 2023
First Online: 21 January 2023
Declarations
:
: The study was approved by the Medical Ethics Committee of the Union Hospital affiliated to Huazhong University of Science and Technology, Wuhan, China (REC ref no. [2019]009). All patients provided written informed consent. This study was registered on ClinicalTrials.gov, NCT04014894.
: Not required.
: Qi Chang and Cheng Liu are employed in Eureka Therapeutics, Inc, and the other authors declare no potential competing interests.